NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/20/2020
Back to search
Official data from USPTO
ANADROL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
10/21/2020
Trademark type
Word
Nice classes
5, 18
Filing date
12/23/1960
Registration date
08/01/1961
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
10/21/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/21/1960
First use in commerce
11/21/1960
Drawing code
1
Owner type
16
Owner location
Canonsburg, PA, US
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ALAVEN PHARMACEUTICAL LLC
UNIMED PHARMACEUTICALS, INC
Syntex (U.S.A.) Inc.
Syntex Laboratories, Inc.
Representatives
ALAVEN PHARMACEUTICAL LLC
Technical classification
Nice Classes
Class 5Class 18
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
Steroid Hormones
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
10/20/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/20/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
08/03/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/03/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/03/2017
NOSU
NOTICE OF SUIT
09/28/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/15/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/15/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/04/2014
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/26/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/26/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
08/16/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/02/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/11/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/04/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/13/2009
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/13/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/16/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/16/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/04/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/14/2009
CFIT
CASE FILE IN TICRS
10/29/2008
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/22/2008
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/21/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/16/2007
CORV
REVIEW OF CORRESPONDENCE COMPLETE
11/04/2006
PAPER RECEIVED
10/13/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2006
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/11/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/04/2006
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/20/2001
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/20/2001
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
08/02/2001
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/25/1984
REN1
REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)
08/01/1981
Continuous trademark protection
Get notified about every new filing that threatens ANADROL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.